Xpert MTB/RIF to diagnose tuberculosis in children

The Lancet Respiratory Medicine

Volumn 3, Issue 6, 2015, Pages 419-421

  Theron, Grant ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC SENSITIVITY; CHILD; DIAGNOSTIC ACCURACY; HUMAN; LIMIT OF DETECTION; META ANALYSIS (TOPIC); NOTE; PEDIATRICS; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; SYSTEMATIC REVIEW (TOPIC); TUBERCULOSIS; TUBERCULOSIS RAPID TEST; MOLECULAR DIAGNOSIS; PROCEDURES; TUBERCULOSIS, PULMONARY;

HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; TUBERCULOSIS, PULMONARY;

EID: 84930868526     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(15)00111-3     Document Type: Note

References (15)

1. Jenkins HE, Tolman AW, Yuen CM, et al. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet 2014, 383:1572-1579.
2. Perez-Velez CM, Marais BJ Tuberculosis in children. N Engl J Med 2012, 367:348-361.
3. Marais BJ, Hesseling AC, Gie RP, Schaaf HS, Enarson DA, Beyers N The bacteriologic yield in children with intrathoracic tuberculosis. Clin Infect Dis 2006, 42:e69-e71.
4. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010, 363:1005-1015.
5. Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 2010, 48:229-237.
6. Yeager H, Lacy J, Smith LR, LeMaistre CA Quantitative studies of mycobacterial populations in sputum and saliva. Am Rev Respir Dis 1967, 95:998-1004.
7. Steingart KR, Sohn H, Schiller I, et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2014, 1. CD009593.
8. Kik SV, Denkinger CM, Casenghi M, Vadnais C, Pai M Tuberculosis diagnostics: which target product profiles should be prioritised?. Eur Respir J 2014, 44:537-540.
9. Detjen AK, DiNardo AR, Leyden J, et al. Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis. Lancet Respir Med 2015, published online March 24. http://dx.doi.org/10.1016/S2213-2600(15)00095-8.
10. Graham SM, Ahmed T, Amanullah F, et al. Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis 2012, 205(suppl 2):S199-S208.
11. Hesseling AC, Schaaf HS, Gie RP, Starke JR, Beyers N A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. Int J Tuberc Lung Dis 2002, 6:1038-1045.
12. Nicol MP, Allen V, Workman L, et al. Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study. Lancet Glob Health 2014, 2:e278-e284.
13. Anderson ST, Kaforou M, Brent AJ, et al. Diagnosis of childhood tuberculosis and host RNA expression in africa. N Engl J Med 2014, 370:1712-1723.
14. Theron G, Peter J, Dowdy D, Langley I, Squire SB, Dheda K Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?. Lancet Infect Dis 2014, 14:527-532.
15. Theron G, Zijenah L, Chanda D, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet 2014, 383:424-435.